New York Wellness Clinic Regulation in 2026: Med Spa Inspections, Ownership Bills and What Is Still Pending

New York already has one of the most restrictive professional-entity frameworks in the country. What changed in 2025 and 2026 is how closely the state is watching. The headline is an inspection sweep, but the more important story for owners may be the bills that would change who is allowed to own and control a medical practice.

The Med Spa Inspection Sweep

In a January 8, 2026 announcement, the New York Department of State said that, with the Department of Health, the Education Department and the New York City Office of Investigations, it inspected 223 med spa businesses and cited 87 for possible violations. Findings included counterfeit or expired drugs, controlled substances and unlicensed injectors. Outcomes ranged from fines to suspensions and revocations, and most cases were still pending. The consumer guidance told people to identify the medical director and to verify the professional entity on the Education Department's website. Other figures circulating, such as a specific share of unlicensed operators, did not come from the Department's release.

Pending Bills That Would Change the Rules

• A11705 (med spa task force): would create a med spa task force under the Secretary of State, require a $1 million bond or insurance and an unannounced inspection every 15 months. Referred to committee in September 2026 with no Senate companion.
• S8442 and A9012 (MSO ownership): would bar non-physician MSOs from holding majority ownership of, or serving as directors of, medical professional corporations. Both are in committee and have not passed either house.
• S9759 (noncompetes): would ban noncompetes for health professionals. It passed the Senate 40 to 21 on June 3, 2026 and is in Assembly Labor.
• S6231A and A1916 (laser hair removal): a technician licensing bill passed the Senate in June 2025 and died in the Assembly in January 2026.

Transaction Review: Article 45-A Unchanged

Article 45-A of the Public Health Law requires 30-day pre-closing notice to the Department of Health for material transactions that add $25 million or more of in-state revenue. The Governor's 2025 and 2026 budget proposals to expand it with a longer preliminary review, a market impact review and post-closing reporting were not enacted. We confirmed this by reading the signed health budget bill, which does not contain the transaction amendment that appeared in an earlier version. Commentary suggests changes could return through regulation or guidance, so watch for that.

Nurse Practitioners

The Nurse Practitioner Modernization Act's independent practice authority, which required 3,600 hours of transition practice, was due to sunset on July 1, 2026. The budget moved the date to July 1, 2030, passed May 27 and signed May 28, 2026. The same bill extended other provisions, including PA practice standards and a telehealth payment parity law to 2028. We found no Education Department guidance specifically on aesthetic delegation.

Telehealth and Controlled Substances

10 NYCRR 80.63, effective May 21, 2025, requires an in-person evaluation before prescribing controlled substances, with exceptions that include telehealth consistent with federal and state law. DEA and HHS have extended federal telemedicine flexibilities through December 31, 2026 and have not finalized a permanent special registration. If those lapse, New York's narrower exceptions could bind testosterone and other controlled-substance prescribing by telehealth.

Federal Items

• GLP-1 compounding: FDA ended shortage-based enforcement discretion in 2025, said in February 2026 it will restrict GLP-1 active ingredients for mass-marketed compounded drugs, and has sent waves of warning letters to telehealth companies. We found no New York Attorney General or Board of Pharmacy GLP-1 action.
• Peptides: FDA's advisory committee met in July 2026. FDA staff opposed adding BPC-157, a reported 8 to 6 committee vote favored it, and adding any peptide to the 503A list still requires FDA rulemaking.
• Hormone therapy: FDA began removing boxed warnings from menopausal hormone therapy labels in November 2025 and approved label changes in February 2026.

What We Did Not Find

We found no New York IV therapy statute or guidance specific to IV, no medical director rule from the Education Department, and no Attorney General action against a med spa or GLP-1 provider in the window. Those are negative findings from our research, not statements that none exist, so confirm with New York counsel.

What a New York Clinic Should Do

• Verify your professional entity and your physician's registration are exactly what the Education Department's website shows, because consumers are being told to check it.
• Check every injector and device operator's license and delegation paperwork. Inspectors focused on unlicensed practice.
• Review your PC and MSO agreements against the ownership bills. If your management company holds majority ownership or director roles in your PC, you may be exposed if a version passes.
• Review noncompete terms in clinician agreements.
• Plan for the December 31, 2026 telemedicine deadline if you prescribe testosterone remotely.
• If you are planning a sale or investment, check Article 45-A notice thresholds.

Where MedGrid Fits

New York is one of the harder states to structure correctly, and the entity work takes longer here than elsewhere. MedGrid connects New York clinics with a New York-licensed physician, forms the physician-owned professional entity and a separate management company, and documents the delegation and protocols inspectors ask about. One thing we emphasize: New York does not allow a PLLC to be converted into a PC, so getting the entity right before filing matters. See our post on how long New York entity formation takes.

Frequently Asked Questions

• Did New York pass a med spa law?: No. Bills to create a med spa task force and to restrict MSO ownership are pending but have not passed.
• What did the 2026 inspections find?: The Department of State said 87 of 223 inspected businesses were cited for possible violations, including unlicensed practice, counterfeit drugs and unlicensed injectors.
• Can nurse practitioners still practice independently?: Yes. The independent practice sunset was extended to July 1, 2030.
• Was Article 45-A expanded?: Not as of our research. The Governor's budget proposals to expand it were not enacted.
• Are noncompetes banned for health professionals in New York?: Not yet. A ban passed the Senate in June 2026 and is pending in the Assembly.

This article is general educational information, not legal advice. It reflects bill pages, agency announcements and law-firm summaries as of the publication date. Pending bills may change or fail. Consult licensed New York healthcare counsel before acting.